Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ADVENTRX Pharmaceuticals Inc (Anx) -- Ignore unavailable to you. Want to Upgrade?

To: Keith Feral who wrote (335)	10/5/2007 3:00:25 PM
From: Keith Feral	Read Replies (2) \| Respond to of 418

As we have to start thinking more about the phase 3 trial, I thought it would be interesting to look at all the methods of delivery. Avastin 1 125 mg Irinotecan 500 mg 5FU + + 20 mg LV bolus Repeat weekly for 4 weeks every 6 weeks 5 mg/kg Avastin Repeat every 2 weeks Avastin 2 500 mg 5FU + 500 mg LV Repeat weekly for 6 weeks every 8 10 mg/kg Avastin Repeat every 2 weeks Avastin 3 Folfox 4 (see above) Repeat every 2 weeks 10 mg Avastin Repeat every 2 weeks Avastin 4 Third line Bolus or Infusional 5FU/LV Repeat weekly for 6 weeks every 8 10 mg Avastin Repeat every 2 weeks (73% received bolus) Cofactor + Avastin 60 mg Cofactor bolus + 450 mg 5FU Repeat weekly for 6 weeks every 7 10 mg Avastin Repeat every 2 weeks Leucovorin + Avastin 20 mg LV bolus? + 500 mg 5FU Repeat weekly for 6 weeks every 7 10 mg Avastin Repeat every 2 weeks